116 related articles for article (PubMed ID: 949007)
41. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
Abrams WB; Solomon HM
Clin Pharmacol Ther; 1969; 10(5):702-9. PubMed ID: 4390109
[No Abstract] [Full Text] [Related]
42. Effects of low extracellular chloride on dopamine release and the dopamine transporter.
Diliberto PA; Jeffs RA; Cubeddu LX
J Pharmacol Exp Ther; 1989 Feb; 248(2):644-53. PubMed ID: 2521901
[TBL] [Abstract][Full Text] [Related]
43. The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines.
Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):135-41. PubMed ID: 3010139
[TBL] [Abstract][Full Text] [Related]
44. Effects of bretylium and guanethidine on 3H-noradrenaline and 3H-serotonin release in rat brain cortex slices.
Schlicker E; Göthert M
Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):196-204. PubMed ID: 6220681
[TBL] [Abstract][Full Text] [Related]
45. The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens.
Stute N; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):124-32. PubMed ID: 6208488
[TBL] [Abstract][Full Text] [Related]
46. The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity.
Lathers CM; Gerard-Ciminera JL; Baskin SI; Krusz JC; Kelliher GJ; Roberts J
Eur J Pharmacol; 1981 Dec; 76(4):371-9. PubMed ID: 6799304
[TBL] [Abstract][Full Text] [Related]
47. [3H]Tyramine uptake by rat liver slices.
Tchercansky DM; Rubio MC; Acevedo C
Pharmacol Res; 1999 Jun; 39(6):479-86. PubMed ID: 10373246
[TBL] [Abstract][Full Text] [Related]
48. Release of purines and noradrenaline by ouabain and potassium chloride from vascular adrenergic nerves.
Katsuragi T; Su C
Br J Pharmacol; 1982 Dec; 77(4):625-9. PubMed ID: 7150870
[TBL] [Abstract][Full Text] [Related]
49. INHIBITION OF NORADRENALINE UPTAKE BY DRUGS.
IVERSEN LL
J Pharm Pharmacol; 1965 Jan; 17():62-4. PubMed ID: 14285701
[No Abstract] [Full Text] [Related]
50. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.
Schömig E; Fischer P; Schönfeld CL; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):502-8. PubMed ID: 2559332
[TBL] [Abstract][Full Text] [Related]
51. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.
Langeloh A; Bönisch H; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):602-10. PubMed ID: 3444477
[TBL] [Abstract][Full Text] [Related]
52. Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):250-4. PubMed ID: 3587371
[TBL] [Abstract][Full Text] [Related]
53. Drug induced changes in the distribution of 14C5-HT in the pithed reserpinized rat.
Fozard JR
Eur J Pharmacol; 1969 Sep; 7(3):248-57. PubMed ID: 4390870
[No Abstract] [Full Text] [Related]
54. Influence of the length of the stimulus period and frequency of sympathetic stimulation on the response of the guinea-pig isolated vas deferens to bretylium, guanethidine and amphetamine.
Day MD
J Pharm Pharmacol; 1965 Oct; 17(10):619-27. PubMed ID: 4379685
[No Abstract] [Full Text] [Related]
55. Influence of desipramine on the uptake and efflux of radiolabelled bretylium and bethanidine in the adventitial and media-intimal layers of rabbit aortic strips.
Batmanglidj Eckhardt S; Maxwell RA; Copp FC
Blood Vessels; 1977; 14(5):303-17. PubMed ID: 871533
[TBL] [Abstract][Full Text] [Related]
56. The uptake of tritiated delta 1-tetrahydrocannabinol by the isolated vas deferens of the rat.
Egan SM; Graham JD; Lewis MJ
Br J Pharmacol; 1976 Apr; 56(4):413-6. PubMed ID: 1260220
[TBL] [Abstract][Full Text] [Related]
57. Presence of a noradrenaline uptake system on a ligated cat sympathetic nerve.
Ceña V; García AG; Pi F; Sánchez-García P
J Physiol; 1986 Mar; 372():351-62. PubMed ID: 3014125
[TBL] [Abstract][Full Text] [Related]
58. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.
Carlsson A; Fuxe K; Hamberger B; Malmfors T
Br J Pharmacol; 1969 May; 36(1):18-28. PubMed ID: 5768100
[TBL] [Abstract][Full Text] [Related]
59. Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents.
Giachetti A; Hollenbeck RA
Br J Pharmacol; 1976 Dec; 58(4):497-504. PubMed ID: 1000128
[TBL] [Abstract][Full Text] [Related]
60. In vitro effect of 6-hydroxydopamine on isolated rat atria.
Kuchi M; Shibata S
Br J Pharmacol; 1972 Mar; 44(3):583-5. PubMed ID: 5040668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
